跳至主要内容
临床试验/DRKS00022038
DRKS00022038招募中不适用

Examination of the excitatory/ inhibitory (E/I) neurotransmitter balance via MRS in patients with substance use disorders

Zentralinstitut für Seelische Gesundheit, Klinik für Abhängiges Verhalten und Suchtmedizin0 个研究点目标入组 200 人开始时间: 2020年11月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
25 Years 至 50 Years(—)
性别
All

入选标准

  • age: between 25 and 50 years
  • Fully Informed Consent
  • Ability to undergo fMRI scanning
  • Written Informed Consent
  • In the clinical groups: diagnosed opiate addiction and opiate substitution treatment or diagnosed cannabis addiction or diagnosed nicotine addiction

排除标准

  • No Written Informed Consent
  • female participants: pregnancy (positive pregnancy test) or currently breastfeeding (anamnestic data)
  • Psychiotic disorders or other severe or difficult to manage psychiatric illnesses
  • Severe neurological or internal comorbidities
  • Psychotropic medication other than antidepressants from the category if SSRIs or Mirtazapin or Pipamperon
  • Severe drug consumption in addition to the index drug or acute intoxication
  • fMRI contraindications

研究者

发起方
Zentralinstitut für Seelische Gesundheit, Klinik für Abhängiges Verhalten und Suchtmedizin

相似试验